Upcoming Meetings in the Series:

2nd ADC Linker & Conjugation
 August 20-22, 2024
 Boston, MA

2nd ADC Process Development Summit
 September 17-19, 2024
 Boston, MA

15th World ADC San Diego
November 4-7, 2024
San Diego, CA

Welcome to the 3rd ADC Analytical Development Summit

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2025 event, please get in touch at adc@hansonwade.com

The updated ICH Q14 guidance from the FDA revising analytical procedures used for release and stability testing has shown higher product quality expectations from regulatory agencies. As analytical studies become an indispensable requirement to progress the antibody-drug conjugate space forward, so has the need for rigorous analytical methodologies that ensure product quality ahead of regulatory submissions.

The 3rd ADC Analytical Development provided a technical deep-dive into optimizing physiochemical methods to better quantify DAR and drug distribution, carry out size variant and charge variant analysis, develop bioassays to improve understanding of the potency in a timely fashion, and better utilize impurity assays to measure free-linker drug and overcome species separation, to ensure attendees are producing a high-quality product within regulatory boundaries.

Over 100+ Attendees including Daiichi Sankyo, Eli Lilly, ADC Therapeutics, AstraZeneca, gained an in-depth but holistic overview of all facets of analytical development that ensure you deliver a high-quality, safe and effective ADC that will progress through regulatory checkpoints.

Designed for analytical development, CMC, and quality control experts within the ADC field, this was an exciting opportunity to foster collaboration, address need-to-know analytical challenges shared by the entire community and set a framework for future regulatory clarity that you could not afford to miss.

Atteendee's optimized the development of physiochemical, potency and impurity assays to gain a better understanding of your final drug product and confidently meet regulatory requirements.

The 2024 Expert Speaker Faculty Included:

Who Attended?:

Companies Attending the ADC Analytical Development Summit

Our 2024 Event Partners:

logo 2
logo 3
MicrosoftTeams-image (61)

Other Events in the World ADC Series:

About the World ADC Series:

The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.